KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Alnylam Pharmaceuticals (ALNY) Interest Coverage Ratio (2020 - 2025)

Historic Interest Coverage Ratio for Alnylam Pharmaceuticals (ALNY) over the last 6 years, with Q4 2025 value amounting to 2.01.

  • Alnylam Pharmaceuticals' Interest Coverage Ratio rose 17463.84% to 2.01 in Q4 2025 from the same period last year, while for Dec 2025 it was 2.41, marking a year-over-year increase of 29306.41%. This contributed to the annual value of 1.99 for FY2025, which is 25922.88% up from last year.
  • Latest data reveals that Alnylam Pharmaceuticals reported Interest Coverage Ratio of 2.01 as of Q4 2025, which was up 17463.84% from 8.29 recorded in Q3 2025.
  • Over the past 5 years, Alnylam Pharmaceuticals' Interest Coverage Ratio peaked at 8.29 during Q3 2025, and registered a low of 7.65 during Q2 2023.
  • Its 5-year average for Interest Coverage Ratio is 2.23, with a median of 3.59 in 2022.
  • In the last 5 years, Alnylam Pharmaceuticals' Interest Coverage Ratio tumbled by 13231.58% in 2024 and then surged by 47047.93% in 2025.
  • Alnylam Pharmaceuticals' Interest Coverage Ratio (Quarter) stood at 5.28 in 2021, then decreased by 19.31% to 6.31 in 2022, then surged by 41.09% to 3.71 in 2023, then rose by 27.35% to 2.7 in 2024, then soared by 174.64% to 2.01 in 2025.
  • Its last three reported values are 2.01 in Q4 2025, 8.29 for Q3 2025, and 0.4 during Q2 2025.